Fortress Biotech Inc (NASDAQ: FBIO) on Friday, soared 14.56% from the previous trading day, before settling in for the closing price of $2.06. Within the past 52 weeks, FBIO’s price has moved between $1.36 and $4.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 26.66% annually for the last half of the decade. The company achieved an average annual earnings per share of 58.60%. With a float of $20.93 million, this company’s outstanding shares have now reached $27.58 million.
In an organization with 186 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 59.95%, operating margin of -169.77%, and the pretax margin is -162.85%.
Fortress Biotech Inc (FBIO) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Fortress Biotech Inc is 24.17%, while institutional ownership is 16.11%. The most recent insider transaction that took place on Sep 23 ’24, was worth 1,404,581. In this transaction PRESIDENT, CEO & CHAIRMAN of this company bought 763,359 shares at a rate of $1.84, taking the stock ownership to the 3,657,264 shares. Before that another transaction happened on Jul 11 ’24, when Company’s President, CEO & Chairman bought 5,000 for $7.48, making the entire transaction worth $37,418. This insider now owns 127,500 shares in total.
Fortress Biotech Inc (FBIO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.50% during the next five years compared to 22.28% growth over the previous five years of trading.
Fortress Biotech Inc (NASDAQ: FBIO) Trading Performance Indicators
Fortress Biotech Inc (FBIO) is currently performing well based on its current performance indicators. A quick ratio of 1.06 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.27, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Fortress Biotech Inc (FBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.71 million. That was better than the volume of 0.42 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.61%. Additionally, its Average True Range was 0.16.
During the past 100 days, Fortress Biotech Inc’s (FBIO) raw stochastic average was set at 100.00%, which indicates a significant increase from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.47% in the past 14 days, which was higher than the 78.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.85, while its 200-day Moving Average is $1.85. However, in the short run, Fortress Biotech Inc’s stock first resistance to watch stands at $2.45. Second resistance stands at $2.55. The third major resistance level sits at $2.73. If the price goes on to break the first support level at $2.17, it is likely to go to the next support level at $1.99. The third support level lies at $1.89 if the price breaches the second support level.
Fortress Biotech Inc (NASDAQ: FBIO) Key Stats
Market capitalization of the company is 74.64 million based on 27,605K outstanding shares. Right now, sales total 84,510 K and income totals -60,640 K. The company made 14,630 K in profit during its latest quarter, and -12,870 K in sales during its previous quarter.
